© Oxford University Press 2006.
NEWS |
Awards, Appointments, Announcements
Harold F. Dvorak, M.D., was honored with the Albert Szent-Györgyi Prize for Progress in Cancer Research. Dvorak works as a professor at Harvard Medical School and acts as Chief of the Department of Pathology at Beth Israel Deacon Medical Center. He won the award for his discovery of vascular permeability factor/vascular endothelial cell growth factor (VPF/VEGF), which helped scientists understand angiogenesis and develop antibodies and therapies to counter VEGF.
The Albert Szent-Györgyi Prize goes to an outstanding scientific achievement in cancer research.
Christopher Baum, M.D., was given the Sir Hans Krebs award for his research showing the consequences of gene transfer into hematopoietic stem cells. Also, Christof von Kalle, M.D., Baum, and two European scientists will receive the Langen Science Award in 2005 for research and discoveries in gene therapy.
Baum and Kalle currently work at the Cincinnati Children's Hospital Medical Center in Ohio. Baum founded the Laboratory for Experimental Cell Therapy in Hannover, Germany, in 2001, and this past July, Kalle was appointed director of the National Center for Tumor Diseases and Chair of the Department of Translational Oncology in Heidelberg, Germany.
Mitsutoshi Nakada, M.D., Ph.D., was awarded the Hoshino Award from the Japan Society for Neuro-Oncology.
Nakada currently works in the Brain Tumor Research Unit at the Translational Genomics Research in Phoenix, Ariz. He was given the award for his research on a family of genes called ephrins and certain ephrins that help target gliomas.
Richard G. Pestell, Ph.D., was named director of the Kimmel Cancer Institute in Philadelphia, Pa. Pestell will also serve as associate dean for cancer programs at Jefferson Medical College and vice president for Oncology Services at Thomas Jefferson University Hospital.
Kishor Bhatia, Ph.D., was appointed director of the AIDS Malignancy Program at the National Cancer Institute. Before this appointment, Bhatia served as program director for the Cancer Diagnosis Program in the Division of Cancer Treatment and Diagnosis.
The American Cancer Society elected new officers to its National Board of Directors for 2005–2006.
Carolyn D. Runowicz, M.D., breast cancer survivor and director of the Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, was elected president. Runowicz is also a professor of obstetrics and gynecology at the University of Connecticut School of Medicine.
Sally West Brooks, RN, was elected Chair of the National Board of Directors. Brooks served as Chair of the Board of the California Division in 1992–1993 and has chaired the Breast and Cervical Cancer Advisory Council for California's Department of Health Services.
Other appointments include the following: Richard Wender, M.D., voted president-elect; Anna Johnson-Winegar, Ph.D., voted chair-elect; Marion Morra, Sc.D., elected vice chair; G. Van Velsor Wolf Jr., J.D., elected treasurer; George W. P. Atkins, elected secretary; Elmer E. Huerta, M.D., elected secretary; and Elizabeth T. H. Fontham, Ph.D., elected second vice president.
The American Cancer Society honored three men with its 2005 Medal of Honor. The award is the society's highest honor.
Sidney Kimmel received the society's first Medal of Honor for Cancer Philanthropy. Kimmel founded the Sidney Kimmel foundation for Cancer Research in 1993, which has given more than $450 million to causes including cancer research, performing arts, and Jewish continuity.
Walter C. Willett, M.D., Ph.D., of Harvard School of Public Health and Medical School received the Medal of Honor for Clinical Research. Willett received the award for his research in epidemiology, the relationship between obesity, diet, and lack of exercise and cancer, and the relationship between oral contraceptive use and breast cancer risk.
Paul L. Modrich, Ph.D., of Duke University and the Howard Hughes Medical Institute, received the Medal of Honor for Basic Research. Modrich was honored for his work with DNA repair and its relation to cancer.
Janet Elaine Porter, Ph.D., was named executive vice president and chief operating officer at the Dana-Farber Cancer Institute. Porter is the associate dean at the University of North Carolina's School of Public Health.
The University of Texas M. D. Anderson Cancer Center in Houston dedicated its new Center for Veterinary Medicine and Surgery to the late John H. Jardine, D.V.M. Jardine was M. D. Anderson's first veterinarian and helped support the center's animal research.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||